KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsReceivables Refunds
Ratios

BioNTech SE (BNTX) Long-Term Debt Issuances (2018 - 2023)

Historic Long-Term Debt Issuances for BioNTech SE (BNTX) over the last 5 years, with Q4 2023 value amounting to $215188.0.

  • BioNTech SE's Long-Term Debt Issuances rose 545.87% to $215188.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $931406.3, marking a year-over-year increase of 1347.07%. This contributed to the annual value of $322782.0 for FY2023, which is 6045.3% down from last year.
  • According to the latest figures from Q4 2023, BioNTech SE's Long-Term Debt Issuances is $215188.0, which was up 545.87% from $108859.0 recorded in Q3 2023.
  • Over the past 5 years, BioNTech SE's Long-Term Debt Issuances peaked at $3.2 million during Q4 2019, and registered a low of $63.91 during Q4 2020.
  • For the 4-year period, BioNTech SE's Long-Term Debt Issuances averaged around $949100.8, with its median value being $214299.7 (2022).
  • As far as peak fluctuations go, BioNTech SE's Long-Term Debt Issuances soared by 21402.84% in 2019, and later tumbled by 9999.8% in 2020.
  • Quarter analysis of 4 years shows BioNTech SE's Long-Term Debt Issuances stood at $3.2 million in 2019, then plummeted by 100.0% to $63.91 in 2020, then soared by 319192.58% to $204049.5 in 2022, then increased by 5.46% to $215188.0 in 2023.
  • Its Long-Term Debt Issuances stands at $215188.0 for Q4 2023, versus $108859.0 for Q3 2023 and $204049.5 for Q4 2022.